Table 1.

Patient Characteristics

Characteristic	All Patients N = 46	Not Assessable N = 11	Assessable N = 35
No. of Females (%)	20 (43)	4 (36)	16 (46)
Median Age, years (range)	66 (34–84)	65 (34–77)	67 (49–84)
Performance Status, no. (%)
0	8 (17)	1 (9)	7 (20)
1	34 (74)	8 (73)	26 (74)
2	4 (9)	2 (18)	2 (6)
Diagnosis , no. (%)
Indolent B-Cell NHL	15 (33)	3 (27)	12 (34)
Intermediate Grade B-NHL	17 (37)	6 (55)	11 (31)
Mantle Cell Lymphoma	7 (15)	1 (9)	6 (17)
T/NK-Cell NHL	7 (15)	1 (9)	6 (17)
Median LDH, (range)	211 (105–1874)	274 (117–1874)	187 (105–418)
Bulky Disease ≥ 5cm, no. (%)	25 (54)	9 (82)	16 (46)
Bone Marrow Involvement, no. (%)	22 (48)	7 (64)	15 (43)
Median No. of Prior Treatments (range)	3 (1–8)	3 (1–7)	3 (1–8)